Level Bio ABFRA:4MB +8.00%23 FCF Yield % is -3.02 as of Jul. 09, 2026. GuruFocus rates FRA:4MB with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, Level Bio AB ranks worse than 57.01% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Level Bio AB's FCF Yield % or its related term are showing as below:
FRA:4MB'
s FCF Yield % Range Over the Past 10 Years
Min: -38.37 Med: -10.21 Max: 5.21
Current: -3.02
During the past 13 years, the highest FCF Yield % of Level Bio AB was 5.21%. The lowest was -38.37%. And the median was -10.21%.
FRA:4MB's FCF Yield % is ranked worse than 57.01% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.32
vs FRA:4MB: -3.02
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Level Bio AB FCF Yield % Related Terms
Level Bio AB FCF Yield % Historical Data
* Premium members only.
The historical data trend for Level Bio AB's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Level Bio AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Level Bio AB FCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Level Bio AB's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Level Bio AB (FRA:4MB) has a FCF Yield % of -3.02 as of Jul. 09, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Level Bio AB and its competitors. According to the industry distribution chart, Level Bio AB ranks #122 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 57%.
Is Level Bio AB's FCF Yield % too high?
Level Bio AB's current FCF Yield % is -3.02. Based on the distribution chart, Level Bio AB ranks #122 out of 214 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Level Bio AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Level Bio AB's FCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Level Bio AB ranks #122 out of 214 companies for FCF Yield %. This places Level Bio AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Diagnostics & Research company?
A good FCF Yield % depends on the Medical Diagnostics & Research industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Level Bio AB and its competitors. Level Bio AB's current FCF Yield % is -3.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Bio AB stock overvalued right now?
Level Bio AB (FRA:4MB) has a current FCF Yield % of -3.02. The current FCF Yield % is -3.02. Level Bio AB's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Level Bio AB (FRA:4MB), the current FCF Yield % is -3.02 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
23GF Score
Get the complete analysis for FRA:4MB
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4MB has been successfully added to your 
